In two intertwined PhD projects, we will study how this transcription factor affects chromatin biology and transcription to deregulate cell behavior. Transcriptomic and proteomic approaches will be used to understand which proteins are hijacked by HMX3 to deregulate epigenetic modifications and gene expression programs. In addition, a drug repurposing screen will be executed to determine whether known drugs exist that inhibit HMX3.